BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7105727)

  • 1. Fibrinolytic activity of uterine fluid in oral contraceptive users.
    Casslén B
    Contraception; 1982 May; 25(5):515-21. PubMed ID: 7105727
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical study and effect on the uterine receptor of the combination Norgestrel-Ethinyl-Estradiol (FH 122-A) in 500 menstrual cycles].
    Lévrier M
    Bord Med; 1970 Jan; 3(1):225-6. PubMed ID: 4948561
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood coagulation and fibrinolysis in women receiving estrogen, gestagen and estrogen-gestagen-contraceptives (author's transl)].
    Lechner K; Hartmann E; Schneider WH; Spona J; Matt K
    Klin Wochenschr; 1976 May; 54(9):431-8. PubMed ID: 1271696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of an oral contraceptive on uterine tonicity in women with primary dysmenorrhea.
    Lalos O; Joelsson I
    Acta Obstet Gynecol Scand; 1981; 60(3):229-32. PubMed ID: 7270089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha fetoprotein levels in women taking oral contraceptives.
    Seppälä M
    Int J Fertil; 1973; 18(4):206-8. PubMed ID: 4359688
    [No Abstract]   [Full Text] [Related]  

  • 7. Blood platelet biochemistry in women receiving steroid contraceptives.
    Briggs M
    Haematologia (Budap); 1973; 7(3):347-67. PubMed ID: 4790074
    [No Abstract]   [Full Text] [Related]  

  • 8. [Oral-cytological studies on the effect of combined contraceptive preparations as compared to menstruation and pregnancy].
    Zellner P; Klinger G
    Stomatol DDR; 1982 Oct; 32(10):673-7. PubMed ID: 6190274
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum tsh and serum t3 levels during normal menstrual cycles and during cycles on oral contraceptives.
    Weeke J; Hansen AP
    Acta Endocrinol (Copenh); 1975 Jul; 79(3):431-8. PubMed ID: 1173500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of contraceptive acceptability of levonorgestrel and ethinyl oestradiol administered in one three-phasic (Trionetta) and one monophasic (Neovletta) version.
    Carlborg L
    Contraception; 1983 May; 27(5):439-52. PubMed ID: 6349925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects, on the endometrium, of a new oral contraceptive: Physiostat].
    Delacroix P
    Rev Fr Gynecol Obstet; 1977; 72(7-9):583-5. PubMed ID: 905717
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes in plasma lipids caused by oral contraceptives].
    Kaffarnik H
    Z Ernahrungswiss Suppl; 1972; 12():Suppl 12:67-72. PubMed ID: 4114609
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of various steroids on the vaginal histology in the rat.
    Jones RC; Edgren RA
    Fertil Steril; 1973 Apr; 24(4):284-91. PubMed ID: 4694503
    [No Abstract]   [Full Text] [Related]  

  • 14. Hormonal contraceptives and plasma sex hormone binding globulin.
    Briggs MH
    Contraception; 1975 Aug; 12(2):149-53. PubMed ID: 49251
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenocortical function of patients using oral contraceptives.
    Kauppila A; Järvinen PA; Ylöstalo P; Reinilä M
    Acta Obstet Gynecol Scand; 1974; 53(2):155-9. PubMed ID: 4362662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Some effects of hormonal contraceptives on the mammary tissue. Influence of duration of use and age os user].
    de Sampaio Junior LF; Stecca J; Neme B
    Matern Infanc (Sao Paulo); 1974; 33(4):509-30. PubMed ID: 4470961
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparison of the sebaceous secretions of the skin of the forehead under the treatment with three oral contraceptives. Diane, Neogynon and Lyndiol (author's transl)].
    Leis D; Clarin A
    Geburtshilfe Frauenheilkd; 1979 Jan; 39(1):54-7. PubMed ID: 422029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral conception and uterine size-ultrasonic study.
    Pirroinen O; Rauramo L
    Am J Obstet Gynecol; 1975 Jun; 122(3):349-51. PubMed ID: 1130457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects on sex hormone binding globulin of different oral contraceptives containing norethisterone and lynestrenol.
    Odlind V; Weiner E; Victor A; Johansson ED
    Br J Obstet Gynaecol; 1980 May; 87(5):416-21. PubMed ID: 6155933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.